Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.01.2023 | Case report

Erlotinib

Haemolytic anaemia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Lim MY, et al. Prolonged Remission of Cancer of Unknown Primary following Initiation of Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria. Case Reports in Hematology 2019: 2 Jul 2019. Available from: URL: http://doi.org/10.1155/2019/2587597 Lim MY, et al. Prolonged Remission of Cancer of Unknown Primary following Initiation of Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria. Case Reports in Hematology 2019: 2 Jul 2019. Available from: URL: http://​doi.​org/​10.​1155/​2019/​2587597
Metadaten
Titel
Erlotinib
Haemolytic anaemia: case report
Publikationsdatum
01.01.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-32455-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Tozinameran

Case report

Multiple drugs

Case report

Antineoplastics

Case report

Multiple drugs

Case report

Mercaptopurine